Hong Kong Pharma Digital Technology Holdings Limited (HKPD)

HKPD Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Net Income	-0.03	1.33	1
Depreciation & Amortization	1.07	0.93	0.71
Loss (Gain) From Sale of Assets	-	-0	-
Loss (Gain) From Sale of Investments	0.04	-	-
Change in Accounts Receivable	-0.92	-2.05	-0.93
Change in Inventory	0.38	-0.74	-0.19
Change in Accounts Payable	0.4	-0.11	0.96
Change in Unearned Revenue	-0.07	-0.08	0.21
Change in Income Taxes	-0.11	0.2	0.02
Change in Other Net Operating Assets	-0.19	0.13	-0.05
Operating Cash Flow	0.57	-0.39	1.73
Capital Expenditures	-0.07	-0.05	-0.11
Sale of Property, Plant & Equipment	-	0.03	-
Sale (Purchase) of Intangibles	-0.09	-0.04	-0
Investment in Securities	-2.3	-	-
Other Investing Activities	-	0.01	-0.01
Investing Cash Flow	-2.45	-0.04	-0.13
Long-Term Debt Issued	1.59	2.14	0.19
Long-Term Debt Repaid	-2.52	-1.77	-1.34
Net Debt Issued (Repaid)	-0.93	0.37	-1.16
Issuance of Common Stock	4.3	0.51	-
Other Financing Activities	-1.38	-0.35	-
Financing Cash Flow	2	0.54	-1.16
Foreign Exchange Rate Adjustments	0.01	0	0
Net Cash Flow	0.12	0.1	0.44
Free Cash Flow	0.5	-0.45	1.61
Free Cash Flow Margin	2.46%	-2.68%	12.84%
Free Cash Flow Per Share	0.05	-0.06	0.24
Cash Interest Paid	0.1	0.08	0.06
Cash Income Tax Paid	0.29	-	-
Levered Free Cash Flow	2.16	-2.93	-
Unlevered Free Cash Flow	2.22	-2.88	-
Change in Working Capital	-0.52	-2.65	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q